Pre-market analysis

1)Nifty closed at 11371.60 up 0.53% and banknifty closed at 22299.60 up 1.36%.

2)Global markets closed positive on friday.

3)Today, US and Europe futures are trading in positive and asian markets opened positive and sgx nifty future is trading at 11422.00 up 0.40%.

4) We may open gap up of around 50-60 pts and follow global futures as the day progresses,good support now stands at 11k mark with resistance at 11500.

5)Support and resistance for Nifty and Banknifty  for intraday.

6)Nifty option pain is at 11300 and banknifty option pain is at 22100.

7)Nifty may trade between 11000 and 11500 and banknifty may trade between 22000 and 22500 for this week.this are very strong support and resistances as per oi chain.

8)Results today 

9)Stocks in news.

ICIC Lombard
ICICI Lombard to merge Bharti AXA's non-life insurance biz with self, create 3rd largest player
The merger would result in an entity with a combined annual premium of Rs 16,447 crore and a market share of nearly 8.7 per cent

The Phoenix Mills
Issue price of QIP Rs 605 , discount of 6.31 per equity share to the floor price of Rs 611.31

Granules India
The US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India Limited for Ramelteon Tablets, 8 mg

Lakshmi vilas bank
Board Meeting on 26th Aug to consider fund raising through equity and bonds

Jindal Stainless
Board meeting on 26th Aug to consider the proposal for raising of funds

10)Results

Rossari Biotech
Q1FY21, YoY
Sales down 14.3% to Rs 109.5 v/s Rs 127.8 cr
EBITDA Up 6.3% to Rs 23.7 v/s Rs 22.3 cr
EBITDA margins Up to 21.6% v/s 17.5%
Profit Up 9.2% to Rs 15.5 v/s Rs 14.2 cr

Oil India
Q1FY21, YoY
Sales Down 48.2% to Rs 1749.7 v/s Rs 3380.9 cr
EBITDA down 86.6% to Rs 181.2 v/s Rs 1353.1 cr
EBITDA margins down to 10.4% v/s 40%
Profit down 96.9% to Rs 26.3 v/s Rs 847.2 cr

Godfrey Phillips Q1, YoY
Net Profit Down 42.8% at 66.6 Cr Vs 116.4 Cr 
Revenue Down 49% at 412.1 Cr Vs 807.6 Cr
EBITDA Down 68.7% at 63.3 Cr Vs 202.5 Cr 
EBITDA Margin At 15.4% Vs 25.1%

PNB Q1
Net Profit at 308.5 Cr Vs 1018.6 Cr (YoY)
NII at 6,748.5 Cr Vs 4,141 Cr (YoY)
Gross NPA at 14.11% Vs 14.21% (QoQ)
Net NPA At 5.39% Vs 5.78% (QoQ)

11)F&O BAN
New in Ban: BHEL, PNB
Still in Ban: ADANIENT, AUROPHARMA, CANBK, IBULHSGFIN, MUTHOOTFIN, NATIONALUM, RBLBANK
Out of Ban: BANKBARODA, CENTURYTEX, IDEA, JINDALSTEL, MANAPPURAM, SUNTV, VEDL

12)Happy Trading

13)Follow our telegram channel 'Optionstraders' for calls on equity and options.

Comments

Popular posts from this blog

Trading Strategies Series Part 6

Pre-market analysis

Pre-market analysis